gabapentin (Neurontin)

Subscribe to Selected New Research on gabapentin

1542 relevant articles (363 outcomes, 403 trials/studies) found for this Drug

Description: can be viewed as a cyclohexane-GABA; an oral medication for add-on therapy in the treatment of partial seizures in adult epilepsy; inhibits dopamine release from rabbit caudate nucleus

Also Known As:

Neurontin; 1-(aminomethyl)cyclohexaneacetic acid; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; Gabapentin Hexal; Gabapentin Stada; Gabapentin-ratiopharm; Hexal brand of gabapentin; Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Stadapharm brand of gabapentin; Warner-Lambert brand of gabapentin; ratiopharm brand of gabapentin

Relationship Network

Drug Context: Research Results

Experts

1.	Pandey, Chandra Kant: 7 articles (02/2008 - 04/2004)
2.	Singh, Prabhat Kumar: 4 articles (02/2008 - 04/2004)
3.	Singh, Uttam: 4 articles (04/2005 - 12/2002)
4.	Guttuso, Thomas: 4 articles (03/2005 - 02/2003)
5.	Solaro, C: 4 articles (09/2001 - 01/2000)
6.	Luszczki, Jarogniew J: 3 articles (10/2008 - 05/2005)
7.	Jensen, Troels S: 3 articles (08/2008 - 12/2004)
8.	Loprinzi, Charles L: 3 articles (11/2007 - 03/2006)
9.	Gilron, Ian: 3 articles (10/2007 - 01/2005)
10.	Luo, Z D: 3 articles (01/2007 - 12/2002)

Related Diseases

1.	Pain (Aches) 06/01/2004 - "Ease of use and broad therapeutic range, in addition to demonstrated efficacy, make gabapentin the drug of choice for most neuropathic pain disorders. " 11/26/2002 - "Patients whose symptoms included pain benefited most from gabapentin. " 09/01/2002 - "BACKGROUND: The anticonvulsant gabapentin has proven effective for neuropathic pain in three large placebo-controlled clinical trials. " 07/01/2002 - "BACKGROUND: The anticonvulsant gabapentin, proven effective for neuropathic pain in two large, placebo-controlled clinical trials, is widely used for treatment of chronic pain. " 03/01/2008 - "After surgery, the patient continued to experience pain; however, his pain resolved completely after several weeks of receiving gabapentin 600 mg 3 times/day. " Order ALL the reference details at left...
2.	Seizures (Seizure) 06/01/2000 - "The objective of this study was to determine the efficacy of gabapentin as adjunctive therapy in doses required to achieve the most effective seizure control. " 08/01/2006 - "More gabapentin patients reported moderate to marked improvement in seizure frequency and intensity/duration of each seizure than placebo patients. " 08/01/2006 - "Gabapentin 1200 mg/day and 1800 mg/day significantly reduced the frequency of refractory seizures compared to placebo. " 12/01/1995 - "Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large double-blind, placebo-controlled, parallel-group clinical trails. " 06/01/1994 - "Gabapentin, has shown significant promise in the treatment of patients with refractory partial seizures and secondarily generalized tonic-clonic seizures. " Order ALL the reference details at left...
3.	Postherpetic Neuralgia 11/01/2001 - "Thus, this study confirms the role of gabapentin as an efficacious and well-tolerated treatment for postherpetic neuralgia." 04/01/1996 - "Gabapentin as a novel treatment for postherpetic neuralgia." 09/01/2004 - "Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia." 10/01/2003 - "Use of gabapentin for postherpetic neuralgia: results of two randomized, placebo-controlled studies." 04/01/2002 - "Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study." Order ALL the reference details at left...
4.	Epilepsy (Aura) 09/01/1997 - "Although the spectrum of efficacy of gabapentin remains to be determined, it is likely to have a major beneficial impact on the treatment of childhood epilepsy." 01/12/2005 - "CONCLUSION: Gabapentin at a dosage of 1200 mg/d is safe and effective in treatment of epilepsy." 10/01/1998 - "Gabapentin is a new antiepileptic drug not appreciably metabolized by the liver in humans, and it appears to be safe and effective in the maintenance therapy of epilepsy in these patients. " 01/12/2005 - "OBJECTIVE: To assess the safety and efficacy of gabapentin in treatment of refractory epilepsy. " 12/01/2003 - "Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients." Order ALL the reference details at left...
5.	Bipolar Disorder (Mania) 01/01/2002 - "No studies to date have shown that gabapentin is effective in bipolar mania or hypomania. " 07/01/1999 - "OBJECTIVE: Open studies and case observations have suggested that gabapentin may be effective in the treatment of bipolar disorder. " 07/01/2001 - "OBJECTIVE: To determine if gabapentin is effective in monotherapy or add-on treatment of non-refractory bipolar disorder in open prospective treatment. " 09/01/1999 - "BACKGROUND: Gabapentin, a new anti-epileptic agent, has been anecdotally reported to be effective in the treatment of mania. " 09/01/1998 - "Recent anecdotal single case reports have suggested that the new antiepileptic drug gabapentin might be effective in the treatment of manic episodes and in the prophylaxis of bipolar disorder. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	lamotrigine (Lamictal)
2.	pregabalin (Lyrica)
3.	Anticonvulsants (Antiepileptic Drugs)
4.	topiramate (Topamax)
5.	Carbamazepine (Tegretol)
6.	tiagabine (Gabitril)
7.	gabapentin (Neurontin)
8.	Opioid Analgesics (Opioids)
9.	Valproic Acid (Valproate, Semisodium)
10.	Vigabatrin

Related Therapies and Procedures

1.	Analgesia
2.	Activities of Daily Living (ADL)
3.	Drug Therapy (Chemotherapy)
4.	Hysterectomy
5.	Relaxation Therapy

Best Treatments:
Research Summary Report
on Pain

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 9246 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>